Physician

Amarinder Singh Garcha, MBBS

According to 2025 Medicare claims, Amarinder Garcha, MBBS (NPI: 1770817744) practices nephrology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is THE NEPHROLOGY GROUP, INC. (NPI: 1205906229; TIN: 770383758) and primary practice location at 93720-2989.

Garcha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 682 traditional Medicare patients, billed 14,294 HCPCS/CPT codes, and received $431,347 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,075 prescription claims across 572 beneficiaries totaling $535,782 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 81 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $176,751 to $431,347. Similarly, Part D prescription costs have risen steadily, from $155,152 to $535,782. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$228K$456K2015 Medicare payment: $176,751 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $223,318 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $232,533 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $322,419 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $375,689 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $334,449 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $456,008 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $378,765 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $407,732 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $431,347 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155474,554$176,751
20165366,434$223,318
20175157,806$232,533
20188285,774$322,419
20197267,982$375,689
20207127,880$334,449
202175311,102$456,008
202268610,761$378,765
202357711,944$407,732
202468214,294$431,347

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$351K$701K2015 Drug cost: $155,152 (USD; Tot_Drug_Cst)2016 Drug cost: $414,653 (USD; Tot_Drug_Cst)2017 Drug cost: $427,382 (USD; Tot_Drug_Cst)2018 Drug cost: $396,905 (USD; Tot_Drug_Cst)2019 Drug cost: $574,893 (USD; Tot_Drug_Cst)2020 Drug cost: $655,412 (USD; Tot_Drug_Cst)2021 Drug cost: $494,405 (USD; Tot_Drug_Cst)2022 Drug cost: $530,561 (USD; Tot_Drug_Cst)2023 Drug cost: $701,201 (USD; Tot_Drug_Cst)2024 Drug cost: $535,782 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152191,559$155,152
20162593,068$414,653
20172633,091$427,382
20184532,599$396,905
20194252,758$574,893
20203542,346$655,412
20213772,230$494,405
20224122,364$530,561
20234522,791$701,201
20245723,075$535,782

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$18K$35K2015 Medicare payment: $896 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,677 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $9,169 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,186 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $17,235 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $15,307 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $15,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $35,011 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,625 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,425 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$896
2016N/R64$4,677
2017N/R118$9,169
2018N/R104$2,186
2019N/R239$17,235
2020N/R223$15,307
2021N/R218$15,679
2022N/R174$35,011
2023N/R89$2,625
2024N/R81$2,425

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more310688$65
80053Blood test, comprehensive group of blood chemicals265598$10
36415Insertion of needle into vein for collection of blood sample273724$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count267609$8
83735Magnesium level265597$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VeltassaPatiromer Calcium Sorbitex1625,306$175,357
VelphoroSucroferric Oxyhydroxide491,566$122,076
ProsolParenteral Amino Acid 20% No.13482,358$48,764
LokelmaSodium Zirconium Cyclosilicate371,391$37,265
Sevelamer CarbonateSevelamer Carbonate975,006$33,091

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7518Mycophenolic acid, oral, 180 mgNN/R13$879
J7507Tacrolimus, immediate release, oral, 1 mgNN/R21$746
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R27$475
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R20$326

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$18Fresenius USA Marketing, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amarinder Singh Garcha, MBBS?

Tedicare shows public-source Medicare data for Amarinder Singh Garcha, MBBS (NPI 1770817744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amarinder Singh Garcha, MBBS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amarinder Singh Garcha, MBBS?

Amarinder Singh Garcha, MBBS is linked to THE NEPHROLOGY GROUP, INC. (billing NPI 1205906229) in the available physician profile data.

Does Amarinder Singh Garcha, MBBS have Open Payments data?

Amarinder Singh Garcha, MBBS has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.